Results 151 to 160 of about 603,469 (215)

Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. [PDF]

Hepatology, 2017
Wang KS, Tiao G, Bass LM, Hertel PM, Mogul D, Kerkar N, Clifton M, Azen C, Bull L, Rosenthal P, Stewart D, Superina R, Arnon R, Bozic M, Brandt ML, Dillon PA, Fecteau A, Iyer K, Kamath B, Karpen S, Karrer F, Loomes KM, Mack C, Mattei P, Miethke A, Soltys K, Turmelle YP, West K, Zagory J, Goodhue C, Shneider BL, Childhood Liver Disease Research Network (ChiLDReN).   +31 more
europepmc   +1 more source

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure. [PDF]

J Clin Pharmacol, 2018
Okour M, Jacobson PA, Ahmed MA, Israni AK, Brundage RC.   +4 more
europepmc   +1 more source

Peroxisome Proliferator-Activated Receptor-γ Prevents Cholesterol Gallstone Formation in C57bl Mice by Regulating Bile Acid Synthesis and Enterohepatic Circulation. [PDF]

Biomed Res Int, 2018
Wang G, Han T, Wang S, Chen M, Sun Y, Fu Z, Fu Z.   +6 more
europepmc   +1 more source

Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation? [PDF]

Hepatology, 2016
Dawson PA.
europepmc   +1 more source

A lipid-tuned bile acid exporter: structural insight into intestinal bile acid efflux. [PDF]

Signal Transduct Target Ther
Kim HM, Nam SW, Jo JK.
europepmc   +1 more source

Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling. [PDF]

Front Med (Lausanne)
Du Y, Qi L, Shi Y, Huang X, Shi X, Liu M, Fang Y, Hu X.   +7 more
europepmc   +1 more source

Development of a simplified population pharmacokinetic-pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment. [PDF]

Cancer Chemother Pharmacol
Makino Y, Ogawa T, Makihara-Ando R, Sakiyama N, Yamazaki M, Naito C, Takayama H, Ueda G, Kohyama S, Todo M, Kuwata Y, Hirasaki M, Hamaguchi T.   +12 more
europepmc   +1 more source

Combination of Multiple-Dose Activated Charcoal and Infusion Therapy That Led to Favorable Outcomes in Colchicine Poisoning: A Case Report. [PDF]

Am J Case Rep
Eiraku M, Miyamoto K, Suzuki K, Abe K, Tamatsukuri T, Kaizaki-Mitsumoto A, Kikuchi K, Yagi M, Numazawa S, Dohi K.   +9 more
europepmc   +1 more source

Pulsatile FXR activation: Timing bile acid-targeted therapy to physiology. [PDF]

Acta Pharmacol Sin
Jiao TY, Li YT, Gonzalez FJ, Xie C.
europepmc   +1 more source

Bile Acid Metabolism in Gout Pathogenesis from Gut-Liver-Joint Crosstalk to Therapeutic Opportunities. [PDF]

Metabolites
Chen B, Chen X, Li J, Gao S, Wang X, Han J.   +5 more
europepmc   +1 more source